Target type: biologicalprocess
Transfer of a nitric oxide (NO) group from one cysteine residue to another. [PMID:19854201, PMID:20972425, PMID:20972426]
Peptidyl-cysteine S-trans-nitrosylation is a post-translational modification where nitric oxide (NO) reacts with a cysteine residue in a protein, forming an S-nitrosothiol (SNO) group. This process is crucial for regulating various cellular functions, including signaling, gene expression, and redox homeostasis.
Here's a detailed breakdown of the process:
1. **NO Generation:** NO is produced by nitric oxide synthase (NOS) enzymes, which catalyze the oxidation of L-arginine to L-citrulline and NO.
2. **NO Diffusion:** NO is a highly diffusible molecule that can readily cross cell membranes. It can then interact with various targets, including cysteine residues in proteins.
3. **S-Nitrosylation Reaction:** The reaction of NO with a cysteine residue involves a two-step process. First, NO reacts with a reactive oxygen species (ROS) like superoxide (O2-) to form peroxynitrite (ONOO-). Peroxynitrite can then directly nitrosylate cysteine residues, forming an SNO group. Alternatively, NO can react with a thiolate anion (RS-) on a cysteine residue, forming an SNO group.
4. **SNO Formation:** The resulting SNO group is a covalent modification that can alter the protein's structure, function, and interactions.
5. **Regulation of Protein Function:** S-nitrosylation can modulate protein activity in various ways, including:
* **Altering protein conformation:** The bulky SNO group can induce conformational changes, affecting protein folding and stability.
* **Modifying enzymatic activity:** S-nitrosylation can either activate or inhibit enzyme activity by affecting substrate binding or catalytic site accessibility.
* **Changing protein-protein interactions:** SNO groups can alter the binding affinity of proteins to other molecules, influencing signaling pathways and cellular processes.
6. **De-nitrosylation:** The SNO group can be removed by denitrosylase enzymes, restoring the cysteine residue to its native state. De-nitrosylation is essential for regulating the duration and specificity of S-nitrosylation.
7. **Biological Significance:** Peptidyl-cysteine S-trans-nitrosylation plays a vital role in various biological processes, including:
* **Cardiovascular system:** NO regulates vascular tone and blood pressure by modulating smooth muscle relaxation.
* **Nervous system:** NO is involved in synaptic plasticity, neurotransmission, and memory formation.
* **Immune system:** NO participates in immune responses by regulating immune cell activation and cytokine production.
* **Cellular signaling:** S-nitrosylation is a crucial signaling mechanism that mediates diverse cellular responses to stimuli.
8. **Pathological Implications:** Dysregulation of S-nitrosylation has been implicated in various diseases, including:
* **Cardiovascular disease:** Imbalances in NO signaling contribute to atherosclerosis, hypertension, and heart failure.
* **Neurodegenerative diseases:** Altered S-nitrosylation patterns are associated with Alzheimer's disease and Parkinson's disease.
* **Cancer:** S-nitrosylation can regulate tumor growth, angiogenesis, and metastasis.
In summary, peptidyl-cysteine S-trans-nitrosylation is a crucial post-translational modification that plays a fundamental role in regulating cellular function and signaling. This process involves the reversible formation of SNO groups on cysteine residues, impacting protein conformation, activity, and interactions. Dysregulation of S-nitrosylation can contribute to various diseases, highlighting its importance in maintaining cellular homeostasis.'
"
Protein | Definition | Taxonomy |
---|---|---|
Glyceraldehyde-3-phosphate dehydrogenase | A glyceraldehyde-3-phosphate dehydrogenase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04406] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
coumarin | 2H-chromen-2-one: coumarin derivative | coumarins | fluorescent dye; human metabolite; plant metabolite |
oxidopamine | oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease). Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals. | benzenetriol; catecholamine; primary amino compound | drug metabolite; human metabolite; neurotoxin |
pentamidine | pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease. Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. | aromatic ether; carboxamidine; diether | anti-inflammatory agent; antifungal agent; calmodulin antagonist; chemokine receptor 5 antagonist; EC 2.3.1.48 (histone acetyltransferase) inhibitor; NMDA receptor antagonist; S100 calcium-binding protein B inhibitor; trypanocidal drug; xenobiotic |
osthol | osthol: from Cnidium monnieri and Angelica pubescens (both Apiaceae); structure given in first source | botanical anti-fungal agent; coumarins | metabolite |
nicotinamide mononucleotide | Nicotinamide Mononucleotide: 3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN. | nicotinamide mononucleotide | Escherichia coli metabolite; mouse metabolite |
2-methyladenine | methyladenine : Any member of the class of 6-aminopurines that is adenine bearing a single methyl substituent. | ||
isopentenyladenosine | Isopentenyladenosine: N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is a member of the cytokinin family of plant growth regulators. N(6)-(Delta(2)-isopentenyl)adenosine : A nucleoside analogue in which adenosine has been modified by substitution at the 6-amino nitrogen by a Delta(2)-isopentenyl group. | N-ribosyl-N(6)-isopentenyladenine; nucleoside analogue | antineoplastic agent; plant growth regulator; plant metabolite |
benzonidazole | benznidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitroimidazol-1-yl)acetic acid with the aromatic amino group of benzylamine. Used for treatment of Chagas disease. benzonidazole: used in treatment of Chagas' disease | C-nitro compound; imidazoles; monocarboxylic acid amide | antiprotozoal drug |
adenosine | quinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlit | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
xanthyletine | xanthyletine: structure | coumarins | |
metrifudil | |||
seselin | seselin: structure in first source | coumarins | metabolite |
n(6)-benzyladenosine | N(6)-benzyladenosine: RN given refers to parent cpd | ||
2-methyladenosine | 2-methyladenosine : A methyladenosine in which the methyl group is located at position 2 on the adenine ring. | methyladenosine | |
n(6)-cyclopentyladenosine | |||
l 783281 | L 783281: structure in first source | ||
scopoletin | hydroxycoumarin | plant growth regulator; plant metabolite | |
7-hydroxycoumarin | 7-oxycoumarin: derivatives have anti-oxidant properties umbelliferone : A hydroxycoumarin that is coumarin substituted by a hydroxy group ay position 7. | hydroxycoumarin | fluorescent probe; food component; plant metabolite |